The complaints also allege that the touted studies are on individual ingredients and do not actually measure the extracts together in a single supplement, so that while they claim to have clinical support for the components of Lemme GLP-1 Daily, they did not study the combination of those extracts in a single supplementmeaning that the supplement has not been clinically tested. Many courts, including those in New York and California, preclude private individuals from challenging advertising based on the advertiser lacking adequate substantiation for their claims, as the plaintiffs have done in the Lemme complaints
Sep 18 2021;13(9)doi:10.3390/nu13093256
[3] [4] GLP-1 medications mimic the action of naturally occurring hormones that play crucial roles in glucose regulation and appetite control
Obesity pharmacotherapy: incretin action in the central nervous system
GLOW Protocol is a proprietary research peptide blend containing BPC-157, TB-500, and GHK-Cu, formulated for laboratory and preclinical investigations
The most debilitating consequence of chronic glutathione depletion is its impact on the mitochondria